Abstract:OBJECTIVE:To prepare a transgenic tumor cell vaccine transfected the fusion gene of murine granulocyte-monocyte colony stimulating factor (mGM-CSF) and human interleukin-2 (hIL-2) using H22 cells, and explore its specific antitumor immunity against hepatocellular carcinoma.METHODS:The eukaryotic vector expressing the fusion gene mGM-CSF/hIL-2 was transfected into H22 cells followed by radiation exposure to construct the tumor cell vaccine, which was used to immunize Balb/c mice by subcutaneous inoculation. The mice inoculated subcutaneously with H22 cells, cells transfected with the empty vector pcDNA(+), or with PBS served as the controls. A week later, H22 cells were injected peritoneally into Balb/c mice for establishing the tumor-bearing model, and their serum levels of interleukin-10 (IL-10) and interferon-gamma (IFN-gamma) were detected using enzyme-linked immunosorbent assay (ELISA) with the survival of the mice recorded. The spleen cells were obtained from the mice immunized with the tumor cell vaccine, the tumor-bearing mice and the normal control mice to assess their cytotoxicity against the parental H22 cells in vitro using (51)C(r)-release assay.RESULTS:The transgenic H22 cell vaccine transfected with mGM-CSF/hIL-2 fusion gene was successfully constructed. The killing rate of H22 cells by the spleen cells from the mice immunized with the transgenic cell vaccine was significantly higher than those by the spleen cells from the tumor-bearing mice or normal control mice (38.3% vs 13.6% and 7.5%, P<0.05). Serum IFN-gamma in the tumor-bearing mice immunized with the transgenic cell vaccine was significantly higher, and serum IL-10 significantly lower than those of the control groups (P<0.01). The survival time of the tumor-bearing mice injected with the transgenic cell vaccine was also significantly prolonged.CONCLUSION:Syngeneic tumor cell vaccine genetically modified by mGM-CSF/hIL-2 fusion gene transfection can elicit specific cellular immune response and enhance the host antitumor immune response to extend the survival time of tumor-bearing mice.

Enhanced Antitumor Effect of EGF R–targeted P21waf-1 and GM-CSF Gene Transfer in the Established Murine Hepatoma by Peritumoral Injection

Systemic genetic transfer of p21 WAF − 1 and GM-CSF utilizing of a novel oligopeptide-based EGF receptor targeting polyplex

Gene Delivery Using a Receptor-Mediated Gene Transfer System Targeted to Hepatocellular Carcinoma Cells.

The potent antitumor effects of combined p16 gene and GM-CSF gene therapy through efficient induction of antitumor immunity

Inhibition of the Growth of Human Hepatoma Cell Line Bothin Vitro Andin Vivo by Transducing CKI Genep21 ( WAF-1 ) with GE7 Targeting Gene Delivery System.

Effects of gamma-interferon gene-modified hepatocytes on murine implanted liver carcinoma

Effective Inhibition Of Cancer Cells By Recombinant Adenovirus Expressing Egfr-Targeting Artificial Microrna And Reversed-Caspase-3

Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma

Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin

Adenovirus-mediated combined P16 gene and GM-CSF gene therapy for the treatment of established tumor and induction of antitumor immunity

Tumor-directed Gene Therapy in Mice Using a Composite Nonviral Gene Delivery System Consisting of the Piggybac Transposon and Polyethylenimine

Enhanced pancreatic cancer gene therapy by combination of adenoviral vector expressing c-erb-B2 (Her-2=neu)-targeted immunotoxin with a replication-competent adenovirus or etoposide

Tumor-targeted gene therapy: strategies for the preparation of ligand–polyethylene glycol–polyethylenimine/DNA complexes

A novel receptor-targeted gene delivery system for cancer gene therapy

In vitro effect of p21WAF-1/CIP1 gene on growth of human glioma cells mediated by EGFR targeted non-viral vector GE7 system

[Application of a Tumor Cell Vaccine Transfected with GM-CSF/IL-2 Fusion Gene for Specific Immunotherapy of Hepatocellular Carcinoma].

Poly-γ-glutamic Acid-Based GGT-targeting and Surface Camouflage Strategy for Improving Cervical Cancer Gene Therapy.

Antitumoral Efficacy By Systemic Delivery Of Heparin Conjugated Polyethylenimine-Plasmid Interleukin-15 Complexes In Murine Models Of Lung Metastasis

Enhancement of p53 gene transfer efficiency in hepatic tumor mediated by transferrin receptor through trans-arterial delivery.

Targeted gene delivery by polyplex micelles with crowded PEG palisade and cRGD moiety for systemic treatment of pancreatic tumors

EGFR-mediated Gene Delivery Targeting to Hepatocarcinoma Cells